Home |
Free Dividend Report |
Stock Splits Calendar |
EXEL Historical Stock Prices |
Preferred Stock Newsletter |
EXEL Options Chain |
Stock Message Boards |
Exelixis (EXEL) has the following price history information. Looking back at EXEL historical stock prices for the last five trading days, on April 15, 2024, EXEL opened at $22.93, traded as high as $23.07 and as low as $22.64, and closed at $22.70. Trading volume was a total of 1.78M shares. On April 16, 2024, EXEL opened at $22.60, traded as high as $23.08 and as low as $22.53, and closed at $22.82. Trading volume was a total of 1.69M shares. On April 17, 2024, EXEL opened at $22.90, traded as high as $23.29 and as low as $22.82, and closed at $22.87. Trading volume was a total of 2.80M shares. On April 18, 2024, EXEL opened at $23.00, traded as high as $23.23 and as low as $22.46, and closed at $22.49. Trading volume was a total of 2.61M shares. On April 19, 2024, EXEL opened at $22.47, traded as high as $22.71 and as low as $22.23, and closed at $22.52. Trading volume was a total of 2.33M shares.
EXEL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Exelixis shares, starting with a $10,000 purchase of EXEL, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/22/2014 | |
End date: | 04/19/2024 | |
Start price/share: | $3.58 | |
End price/share: | $22.52 | |
Dividends collected/share: | $0.00 | |
Total return: | 529.05% | |
Average Annual Total Return: | 20.19% | |
Starting investment: | $10,000.00 | |
Ending investment: | $62,904.74 | |
Years: | 10.00 |
EXEL Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/15/2024 | $22.93 | $23.07 | $22.64 | $22.70 | 1.78M |
04/16/2024 | $22.60 | $23.08 | $22.53 | $22.82 | 1.69M |
04/17/2024 | $22.90 | $23.29 | $22.82 | $22.87 | 2.80M |
04/18/2024 | $23.00 | $23.23 | $22.46 | $22.49 | 2.61M |
04/19/2024 | $22.47 | $22.71 | $22.23 | $22.52 | 2.33M |
About Exelixis |
Exelixis is an oncology company that engages in creating medicines and combination regimens for cancer care. Co.'s products include: CABOMETYX® (cabozantinib) tablets, which are approved both alone and in combination with Bristol-Myers Squibb Company's OPDIVO® (nivolumab) for renal cell carcinoma; COMETRIQ® (cabozantinib) capsules, which are approved for progressive, metastatic medullary thyroid cancer; COTELLIC® (cobimetinib), an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of melanoma; and MINNEBRO® (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan. |
EXEL Historical Closing Prices | |
Date | Close |
04/15/2024 | $22.70 |
04/16/2024 | $22.82 |
04/17/2024 | $22.87 |
04/18/2024 | $22.49 |
04/19/2024 | $22.52 |
Healthcare Historical Prices |
EXEL is categorized under the Healthcare sector; below are some other companies in the same sector:
EYE Historical Stock Prices Also explore: EXEL shares outstanding history
Free EXEL Email Alerts:
|
EXEL Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.